首页> 外文期刊>Clinical Endocrinology >Follicular and endocrine dose responses according to anti-Mullerian hormone levels in IVF patients treated with a novel human recombinant FSH (FE 999049)
【24h】

Follicular and endocrine dose responses according to anti-Mullerian hormone levels in IVF patients treated with a novel human recombinant FSH (FE 999049)

机译:在使用新型人重组FSH治疗的IVF患者中,根据抗Mullerian激素水平的卵泡和内分泌剂量反应(FE 999049)

获取原文
获取原文并翻译 | 示例
           

摘要

Objective To study the association between serum anti-Mullerian hormone (AMH) levels and follicular development and endocrine responses induced by increasing doses (5.2-12.1 mu g/day) of a novel recombinant human FSH (rhFSH, FE 999049) in patients undergoing in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) in a GnRH antagonist protocol.
机译:目的研究经剂量增加的新型重组人FSH(rhFSH,FE 999049)所致患者的血清抗Mullerian激素(AMH)水平与卵泡发育和内分泌反应之间的关系,该剂量增加(5.2-12.1μg /天) GnRH拮抗剂方案进行体外受精(IVF)/胞浆内精子注射(ICSI)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号